Table 6 |.
MC3 formulation details for the microfluidic mixing method
| MC3 formulations | Complete lipid mix in EtOH (μL) | EtOH (μL) | mRNA stock (μL) | Citrate buffer (μL) | Total EtOH phase (μL) | Total aqueous phase (μL) | Final volume after compensation with PBS (μL) |
|---|---|---|---|---|---|---|---|
| MC3 LNPs | 42.00 (from Box 2, step 7) | 258.0 | 20 | 880 | 300 | 900 | 1,000 |
| 50% DOTAP MC3 lung SORT LNPs | 27.80 (from Box 2, step 8) | 272.2 | 20 | 880 | 300 | 900 | 1,000 |
| 30% 18PA MC3 spleen SORT LNPs | 42.80 (from Box 2, step 9) | 257.2 | 20 | 880 | 300 | 900 | 1,000 |